Publicaciones en colaboración con investigadores/as de University of Queensland (62)

2022

  1. A global experiment on motivating social distancing during the COVID-19 pandemic

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 22

  2. An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma

    Cancers, Vol. 14, Núm. 11

  3. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

    Cancer Letters, Vol. 529, pp. 70-84

  4. Developing Clinical and Research Priorities for Pain and Psychological Features in People With Patellofemoral Pain: An International Consensus Process With Health Care Professionals

    Journal of Orthopaedic and Sports Physical Therapy, Vol. 52, Núm. 1, pp. 29-39

  5. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  6. Erratum: A global experiment on motivating social distancing during the COVID-19 pandemic (Proceedings of the National Academy of Sciences of the United States of America (2022) 119 (e2111091119) DOI: 10.1073/pnas.2111091119)

    Proceedings of the National Academy of Sciences of the United States of America

  7. Erratum: Author Correction: A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic (Nature human behaviour (2021) 5 8 (1089-1110))

    Nature human behaviour

  8. Erratum: Publisher Correction: Situational factors shape moral judgements in the trolley dilemma in Eastern, Southern and Western countries in a culturally diverse sample (Nature human behaviour (2022) 6 6 (880-895))

    Nature human behaviour

  9. In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 Countries

    Affective Science, Vol. 3, Núm. 3, pp. 577-602

  10. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268